Fortune Pharmacal
Hong Kong 104 employees Updated 9 July 2026
Fortune Pharmacal is a finished-dose manufacturer based in Hong Kong. It appears in 42 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DH (HK), NMPA (CN) and Health Canada. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 June 2025 as VAI.
1
registered plants
1 with an FDA FEI number
42
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 6 June 2025 VAI US FDA
- 13 July 2018 VAI US FDA
- 29 August 2014 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Hong Kong, Hong Kong | 3003952755 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| DH (HK) | 37 | None |
| NMPA (CN) | 4 | None |
| Health Canada | 1 | None |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Fortune Pharmacal comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 6 June 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates